Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor vs Autologous FMT for Irritable Bowel Syndrome
NCT04691544Phase 3Active, not recruiting
- Sponsor
- University Hospital of North Norway
- Start
- May 2021
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in irritable bowel syndrome (IBS), sponsored by University Hospital of North Norway. Started May 2021; status: active, not recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04691544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04691544.